Development of a C-Terminal Site-Specific PEGylated Analog of GLP-1 with Improved Anti-Diabetic Effects in Diabetic Mice.
- Published in:
- Drug Development Research, 2013, v. 74, n. 3, p. 186, doi. 10.1002/ddr.21059
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2013 AND VI 74 AND IP 3
Results: 7
1
2
Drug-Induced Convulsions in Nonclinical Safety Studies: Implication for Clinical Development.
- Published in:
- Drug Development Research, 2013, v. 74, n. 3, p. 155, doi. 10.1002/ddr.21061
- By:
- Publication type:
- Article
3
Synthesis and Macrofilaricidal Activity of Substituted 2-Hydroxy/5-Hydroxy/2-Methyl-1,4-Naphthoquinones.
- Published in:
- Drug Development Research, 2013, v. 74, n. 3, p. 216, doi. 10.1002/ddr.21065
- By:
- Publication type:
- Article
4
In Vivo Preclinical Evaluation of a Promising Antiarrhythmic Agent, EGIS-7229.
- Published in:
- Drug Development Research, 2013, v. 74, n. 3, p. 173, doi. 10.1002/ddr.21058
- By:
- Publication type:
- Article
5
Antiarrhythmic Efficacy of CPUY11018 Under Pathological Conditions.
- Published in:
- Drug Development Research, 2013, v. 74, n. 3, p. 194, doi. 10.1002/ddr.21060
- By:
- Publication type:
- Article
6
Antidepressant-Like Activity of Agomelatine in the Mouse Unpredictable Chronic Mild Stress Model.
- Published in:
- Drug Development Research, 2013, v. 74, n. 3, p. 203, doi. 10.1002/ddr.21064
- By:
- Publication type:
- Article
7
Synthesis and Evaluation as Antitubercular Agents of 5-Arylethenyl and 5-(Hetero)aryl-3-Isoxazolecarboxylate.
- Published in:
- Drug Development Research, 2013, v. 74, n. 3, p. 162, doi. 10.1002/ddr.21057
- By:
- Publication type:
- Article